Acitretin

What is acitretin?

Acitretin is an oral retinoid (vitamin-A derivative) used to treat severe psoriasis, usually at a dose of 0.25–1 mg per kg body weight per day. It is best taken after a meal because it needs fat to be absorbed through the gut wall.

Acitretin is available as 10 mg and 25 mg capsules. Trade names include Neotigason™ and Novatretin®. Since March 2009, PHARMAC funding in New Zealand requires Special Authority application by a dermatologist or vocationally registered general practitioner. Restrictions apply.

What is acitretin used for?

Acitretin is particularly useful for some types of psoriasis including pustular psoriasis, erythrodermic psoriasis, and psoriasis affecting hands and feet. It is not effective for psoriatic arthritis.

It is occasionally used to treat other skin conditions including:

• Palmoplantar pustulosis
• Hand dermatitis (when very thick and scaly)
• Darier disease
• Lichen planus
• Lichen sclerosus
• Lupus erythematosus
• Cutaneous T-cell lymphoma
• Extensive granuloma annulare
• Severe ichthyosis
• Widespread actinic keratoses and skin cancers
• Extensive warts

Risk of acitretin in pregnancy and during breastfeeding

Acitretin MUST NOT be taken in pregnancy; it can damage an unborn child and cause congenital disabilities. Strict birth control measures must be used during treatment and for three years after stopping acitretin. Therefore, acitretin is rarely prescribed to females of child-bearing potential. If it is, they will be asked to have a blood pregnancy test before treatment and regularly during treatment. People on acitretin should not donate blood during treatment or for three years afterwards. Acitretin is also contraindicated while breastfeeding.

It does not affect male sexual function or offspring, so males of all ages can take it.

What is the mechanism of action of acitretin?

Acitretin is a metabolite of an earlier antipsoriatic retinoid, etretinate. Etretinate (Tigason™) is no longer available in New Zealand.

Acitretin is thought to work in psoriasis by slowing down the proliferation of the skin cells. A response is noted in more than half of treated patients. Improvement begins about two weeks after starting treatment and is maximum after about twelve weeks. The affected skin either peels off or gradually clears.

Some patients are treated with acitretin for a few months, repeated from time to time, while others remain on the acitretin long term.

In resistant cases, acitretin can be combined with other antipsoriatic drugs and phototherapy.

What are the side effects and risks of acitretin?

Acitretin has side effects that may limit the dose that can be used.

• Dryness of lips — apply lip salve frequently, especially when outdoors.
• Dry nostrils that may crust and bleed: petroleum jelly can help.
• Dry eyes — use artificial tear eye drops.
• Dry reddened skin: apply moisturisers frequently.
• Peeling skin, especially hands and feet; apply moisturisers frequently.
• Fragile soft skin: protect it from injury.
• With long-term use, thin, ridged, and brittle nails.
• Generalised hair shedding and thinning may occur; this is usually temporary although permanent thinning has been reported.
• Change in colour and texture of hair may occur.
• Increased susceptibility to sunburn: protect your skin from the sun. Use a broad-spectrum sunscreen and dress up well. If you are receiving phototherapy, advise your therapist that you are taking acitretin. A reduction in dose may be necessary.
• Skin infections, especially with Staphylococcus aureus (impetigo, boils or nail fold paronychia).
• Aggravation of skin complaint: this is often temporary and followed by improvement, but if a severe flare occurs you should tell your dermatologist and stop taking the acitretin.
• Headaches: if these are severe or accompanied by visual problems, inform your dermatologist and stop the acitretin; the symptoms could be caused by an increase in pressure on the brain.
• Muscle, joint or bone aches, especially with exercise; reduce exercise if needed.
• Hyperlipidaemia (raised blood fats — cholesterol and triglyceride), detected by blood tests, which are best taken when fasting (on an empty stomach). The level of the blood fats is compared with a pre-treatment test. High blood fats are more likely in people with diabetes and in those who drink a lot of alcohol. If the blood fats are too high, a particular low fat and low sugar diet may be recommended, a lipid-lowering medication may be prescribed, or the dose of acitretin may be reduced or stopped.
• Rarely, acitretin may result in disturbed liver function (hepatitis). It should be discontinued if this occurs, and it would be unwise to retake it.
• Mood changes; high dose retinoids can cause mood change including irritability, aggression and depression.

Acitretin nail thinning 

Acitretin nail thinning 

Acitretin diffuse hair loss 

Interactions with other medications

Acitretin should not usually be taken at the same time as the following medications (there may be rare exceptions):

• Vitamin A or any other retinoid (eg, isotretinoin)
• Tetracycline or one of its derivatives is contraindicated as both tetracyclines and retinoids can increase intracranial pressure
• Methotrexate
• Phenytoin.

It is best to avoid alcohol when on acitretin, especially if triglyceride levels are high.

Approved datasheets are the official source of information for medicines, including approved uses, doses, and safety information. Check the individual datasheet in your country for information about medicines.

We suggest you refer to your national drug approval agency such as the Australian Therapeutic Goods Administration (TGA), US Food and Drug Administration (FDA), UK Medicines and Healthcare products regulatory agency (MHRA) / emc, and NZ Medsafe, or a national or state-approved formulary eg, the New Zealand Formulary (NZF) and New Zealand Formulary for Children (NZFC) and the British National Formulary (BNF) and British National Formulary for Children (BNFC).